TRPM8 and neoplasm: This mechanism results in the inhibition of cell adhesion and migration in PCa-derived endothelial cells and in epithelial PCa cells, thus making TRPM8 an appealing candidate to block both tumor invasiveness and angiogenesis (Genova et al., 2017; Chinigo et al., 2022).